Applied BioCode (6598) — Free Cash Flow Generation Index

Latest as of September 2022: -0.89x

Applied BioCode (6598) has a Free Cash Flow Generation Index of -0.89x as of September 2022. Free cash flow of NT$-5.65 Million represents -1% of operating cash flow (NT$6.35 Million). Explore 6598 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

-0.89x
Free Cash Flow / Operating CF

Free Cash Flow

NT$-5.65 Million
TWD

Operating Cash Flow

NT$6.35 Million
TWD

Capital Expenditures

NT$12.00 Million
TWD

Applied BioCode Free Cash Flow Generation Index (2022–2022)

Historical FCF Generation Index trend for Applied BioCode across 1 annual periods. For the full cash flow conversion analysis, see Applied BioCode (6598) cash flow conversion.

Annual Free Cash Flow Generation for Applied BioCode (2022–2022)

Year-by-year Free Cash Flow Generation Index for Applied BioCode. Check Applied BioCode total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.

Year FCG Index Free Cash Flow (TWD) Operating CF Capital Expenditures YoY Change
2022 0.85x NT$123.73 Million NT$145.87 Million NT$22.14 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).